Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Clinical Investigators - Disqualification Proceedings
  • Print
  • Share
  • E-mail
  • FDA Home
  • Clinical Investigators - Disqualification Proceedings
-

Compliance and Enforcement

Regulatory Activities

Clinical Investigators - Disqualification Proceedings


Return to Introductory Page
Download Clinical Investigators - Disqualification Proceedings data in Microsoft Excel web format  Click on this link to download all data from the selected searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players .



Advanced Search

   No. of Records Found:  230
Name Center Status Date of status Date NIDPOE Issued Date NOOH Issued Link to NIDPOE Letter Link to NOOH Letter
Spiers, Alexander S., MD CDER Reinstated 12/14/1990
Splitter, Samuel, MD CDER Disqualified 07/29/1968
Sriratana, Pramern, MD CDER Restricted 06/10/1988
Steele, Peter P., MD CDER Disqualified 04/02/1986
Steen, Stephen N., MD Burea Not Disqualified – Adequate Assurances1 09/05/1985
Stolman, Lewis P., MD CDER Adequate Assurances1 03/11/1991 11/16/1990
Straus, Marc J., MD CDER Disqualified 05/18/1982
Streb, Richard A., MD CDER Disqualified 01/03/1997
Summers, William K., MD CDER Restrictions Removed 07/24/2007 05/04/1989
Swanson, Todd V., MD CDRH Restricted 04/10/2005 05/05/2004 PDF Text
Taber, David O., MD CDER Totally Restricted 06/17/1982 09/26/1980 02/09/1981
Teplick, Steven K., MD CDER Disqualified 03/08/1994 04/12/1990 03/22/1991
Tewari, Anand, MD CBER Disqualified 11/18/1993 03/23/1995
Togias, Alkis, MD CDER Restrictions Removed 09/26/2006
Tonkon, Melvin, MD CDER Not Disqualified 03/30/1999 12/23/1998
Valdez, Mario P., MD CDER Totally Restricted 02/03/1994
Vestal, James C., MD CDER Disqualified 05/05/2008 05/09/2007 PDF Text
Villaman-Bencosme, Yvelice A., MD CDER Pending 01/18/2022 01/18/2022 09/26/2022 PDF PDF
Vriesendorp, Huibert M., MD, PhD CBER Disqualified 12/31/2001 11/19/1996 09/19/1997
Wallens, William T., MD CDER Disqualified 08/22/1983
Weiss, Jerome, MD CDER Disqualified 12/31/1984
Wholey, Mark H., MD CDRH Restricted 07/19/2006 10/21/2005 PDF Text
Williams, Joseph L., MD CDER Restrictions Removed (reinstated by correspondence) 05/15/2003 07/01/1998 PDF
Wilson, James M., MD, PhD CBER Restricted 02/09/2005 11/30/2000 02/08/2002 PDF PDF Text
Winchester, James F., MD CDER Restrictions Removed 05/24/1985 05/24/1982
Wong, David T., MD CDER Totally Restricted 07/09/1982 10/06/1980
Young, Robert E., MD CDER Disqualified 10/15/1982
Zabalgoitia-Reyes, Miguel, MD CDER Disqualified 07/02/2009 06/08/2009 PDF Text
Zackheim, Herschel S., MD CDER Restricted 08/23/1988 03/30/1988
Ziering, William H., MD CDER Disqualified 05/20/2008 11/06/1998 08/16/1999 PDF PDF Text

Prev  |  Next  |  1  |  2  |  3  |  4  |  [5]  |  First  |  Last  |  All

1.Under regulations in effect until 1987, investigators who met the standard for disqualification (repeated or deliberate failure to comply with applicable requirements) could potentially avoid disqualification and continue to be eligible to receive investigational products if they could provide FDA with adequate assurances of future compliance with requirements applicable to the use of investigational drugs and biologics. The provisions for adequate assurances are no longer in the regulations.

-
-